| |
| |
|
| Insider
Information: |
Brister Mark |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
49,832 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,426,345 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
49,832 |
|
|
| Total
Value |
$1,426,345 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
DexCom Inc |
DXCM |
VP Advanced Developmen... |
2006-05-02 |
10,967 |
|
0 |
Premium* |
|
|
ReShape Lifesciences Inc |
RSLS |
|
2019-08-06 |
38,865 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RSLS |
ReShape Lifesciences Inc |
Chief Technology Officer |
• – – |
2019-08-06 |
4 |
B |
$4.00 |
$20,000 |
D/D |
5,000 |
38,865 |
0.01 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Technology Officer |
• – – |
2018-08-23 |
4 |
A |
$1.82 |
$194,998 |
D/D |
107,142 |
338,634 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Technology Officer |
• – – |
2018-04-30 |
4 |
A |
$3.27 |
$8,574 |
D/D |
2,622 |
166,492 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Technology Officer |
• – – |
2018-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
65,000 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
Chief Technology Officer |
• – – |
2017-10-31 |
4 |
A |
$7.17 |
$13,336 |
D/D |
1,860 |
163,870 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
VP of Research and Development |
• – – |
2017-04-30 |
4 |
A |
$9.03 |
$13,997 |
D/D |
1,550 |
162,010 |
0 |
- |
|
| RSLS |
ReShape Lifesciences Inc |
VP of Research and Development |
• – – |
2016-10-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
160,460 |
|
- |
|
| DXCM |
DexCom Inc |
VP Advanced Development Teams |
• – – |
2006-05-02 |
4 |
S |
$24.00 |
$1,200,000 |
D/D |
(50,000) |
10,967 |
|
- |
|
| DXCM |
DexCom Inc |
VP, Advanced Development Teams |
• – – |
2005-04-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
58,856 |
|
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
